225 related articles for article (PubMed ID: 7657517)
1. Metalloproteinases in tumor progression: the contribution of MMP-9.
Himelstein BP; Canete-Soler R; Bernhard EJ; Dilks DW; Muschel RJ
Invasion Metastasis; 1994-1995; 14(1-6):246-58. PubMed ID: 7657517
[TBL] [Abstract][Full Text] [Related]
2. Collagenases in cancer.
Ala-aho R; Kähäri VM
Biochimie; 2005; 87(3-4):273-86. PubMed ID: 15781314
[TBL] [Abstract][Full Text] [Related]
3. Interstitial collagenases as markers of tumor progression.
Brinckerhoff CE; Rutter JL; Benbow U
Clin Cancer Res; 2000 Dec; 6(12):4823-30. PubMed ID: 11156241
[TBL] [Abstract][Full Text] [Related]
4. [Matrix metalloproteinases and colorectal cancer].
Roeb E; Matern S
Med Klin (Munich); 2003 Dec; 98(12):763-70. PubMed ID: 14685678
[TBL] [Abstract][Full Text] [Related]
5. Matrix metalloproteinase 9 (gelatinase B) is expressed in multinucleated giant cells of human giant cell tumor of bone and is associated with vascular invasion.
Ueda Y; Imai K; Tsuchiya H; Fujimoto N; Nakanishi I; Katsuda S; Seiki M; Okada Y
Am J Pathol; 1996 Feb; 148(2):611-22. PubMed ID: 8579123
[TBL] [Abstract][Full Text] [Related]
6. Expression of collagenases-1 and -3 and their inhibitors TIMP-1 and -3 correlates with the level of invasion in malignant melanomas.
Airola K; Karonen T; Vaalamo M; Lehti K; Lohi J; Kariniemi AL; Keski-Oja J; Saarialho-Kere UK
Br J Cancer; 1999 May; 80(5-6):733-43. PubMed ID: 10360651
[TBL] [Abstract][Full Text] [Related]
7. [Metalloproteinases in tumor progression. Review].
Arvelo F; Cotte C
Invest Clin; 2006 Jun; 47(2):185-205. PubMed ID: 16886780
[TBL] [Abstract][Full Text] [Related]
8. Combined treatment with serine protease inhibitor aprotinin and matrix metalloproteinase inhibitor Batimastat (BB-94) does not prevent invasion of human esophageal and ovarian carcinoma cells in vivo.
Della Porta P; Soeltl R; Krell HW; Collins K; O'Donoghue M; Schmitt M; Krüger A
Anticancer Res; 1999; 19(5B):3809-16. PubMed ID: 10628317
[TBL] [Abstract][Full Text] [Related]
9. Matrix-degrading metalloproteinases in tumor progression.
Matrisian LM; Wright J; Newell K; Witty JP
Princess Takamatsu Symp; 1994; 24():152-61. PubMed ID: 8983072
[TBL] [Abstract][Full Text] [Related]
10. [Roles of serine proteases and matrix metalloproteinases in tumor invasion and angiogenesis].
Masson V
Bull Mem Acad R Med Belg; 2006; 161(5):320-6. PubMed ID: 17283905
[TBL] [Abstract][Full Text] [Related]
11. High serum levels of matrix metalloproteinase-9 and matrix metalloproteinase-1 are associated with rapid progression in patients with metastatic melanoma.
Nikkola J; Vihinen P; Vuoristo MS; Kellokumpu-Lehtinen P; Kähäri VM; Pyrhönen S
Clin Cancer Res; 2005 Jul; 11(14):5158-66. PubMed ID: 16033831
[TBL] [Abstract][Full Text] [Related]
12. [Zymography--method for quantitation of activity on gelatinase A (pro-MMP-2, 72 kDa) and gelatinase B (pro-MMP-9, 92 kDa) in serum of patients with breast cancer].
Sliwowska I; Kopczyński Z
Wiad Lek; 2007; 60(5-6):241-7. PubMed ID: 17966888
[TBL] [Abstract][Full Text] [Related]
13. Matrix metalloproteinases-2 and -9 are expressed in human neuroblastoma: contribution of stromal cells to their production and correlation with metastasis.
Sugiura Y; Shimada H; Seeger RC; Laug WE; DeClerck YA
Cancer Res; 1998 May; 58(10):2209-16. PubMed ID: 9605768
[TBL] [Abstract][Full Text] [Related]
14. Expression of gelatinase B and the extracellular matrix metalloproteinase inducer EMMPRIN in benign and malignant pigment cell lesions of the skin.
van den Oord JJ; Paemen L; Opdenakker G; de Wolf-Peeters C
Am J Pathol; 1997 Sep; 151(3):665-70. PubMed ID: 9284814
[TBL] [Abstract][Full Text] [Related]
15. Tumor and stromal expression of matrix metalloproteinases and their role in tumor progression.
Crawford HC; Matrisian LM
Invasion Metastasis; 1994-1995; 14(1-6):234-45. PubMed ID: 7657516
[TBL] [Abstract][Full Text] [Related]
16. Matrix metalloproteinase production by bone marrow mononuclear cells from normal individuals and patients with acute and chronic myeloid leukemia or myelodysplastic syndromes.
Ries C; Loher F; Zang C; Ismair MG; Petrides PE
Clin Cancer Res; 1999 May; 5(5):1115-24. PubMed ID: 10353746
[TBL] [Abstract][Full Text] [Related]
17. Membrane associated matrix metalloproteinases in metastasis.
Ellerbroek SM; Stack MS
Bioessays; 1999 Nov; 21(11):940-9. PubMed ID: 10517867
[TBL] [Abstract][Full Text] [Related]
18. Control of type IV collagenase activity by components of the urokinase-plasmin system: a regulatory mechanism with cell-bound reactants.
Mazzieri R; Masiero L; Zanetta L; Monea S; Onisto M; Garbisa S; Mignatti P
EMBO J; 1997 May; 16(9):2319-32. PubMed ID: 9171346
[TBL] [Abstract][Full Text] [Related]
19. Inhibition by galloylglucose (GG6-10) of tumor invasion through extracellular matrix and gelatinase-mediated degradation of type IV collagens by metastatic tumor cells.
Ata N; Oku T; Hattori M; Fujii H; Nakajima M; Saiki I
Oncol Res; 1996; 8(12):503-11. PubMed ID: 9160354
[TBL] [Abstract][Full Text] [Related]
20. The role of the IGF-I receptor in the regulation of matrix metalloproteinases, tumor invasion and metastasis.
Zhang D; Samani AA; Brodt P
Horm Metab Res; 2003; 35(11-12):802-8. PubMed ID: 14710361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]